- OBD pursuing EpiSwitch as companion diagnostics
- Grant of Options
- Half-year Report
- OBD's PSE test to be used in NCI trial
- OBD develops multi-cancer diagnostic test for dogs
- Notice of Results
- OBD partners with Goodbody Clinic on PSE test
- OBD partners with The London Clinic for PSE & CiRT
- OBD and King's College London collaborate on RA
- Holding(s) in Company
More ▼
Key statistics
As of last trade, Oxford Biodynamics PLC (LMQ:FRA) traded at 0.0745, 144.26% above the 52 week low of 0.0305 set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0745 |
---|---|
High | 0.0745 |
Low | 0.0745 |
Bid | 0.0525 |
Offer | 0.138 |
Previous close | 0.076 |
Average volume | 0.00 |
---|---|
Shares outstanding | 311.86m |
Free float | 263.53m |
P/E (TTM) | -- |
Market cap | 25.32m GBP |
EPS (TTM) | -0.0643 GBP |
Data delayed at least 15 minutes, as of Jul 30 2024 07:03 BST.
More ▼